BioPharma Dive ٢٠ أبريل ٢٠٢٦ AACR 2026: Revolution’s next prospect, Merck’s reveal and a lung cancer battle
BioPharma Dive ١٢ فبراير ٢٠٢٦ Sanofi, looking for more ‘rigor,’ swaps CEO Hudson for ex-Merck KGaA chief Garijo